FOR MANY YEARS clinicians have
sidered alcoholic heart disease as a specific entity.'-5 In the German literature, the cardiac symptoms of chronic alcoholics were described under the heading of 'Bierherz." There is still doubt however whether alcoholic heart disease has in fact enough specific pathological and biochemical abnormalities to justify its position as an independent disease.6 It is rather rare among chronic alcoholics, and it is nearly always accompanied by important nutritional deficiencies. In March 1965 at an international meeting in Brussels on the nonobstructive cardiomyopathies, a new heart disease in chronic beer drinkers was described. 7 This disease consists essentially of massive pericardial effusion, low cardiac output, and raised venous pressure accompanied in a certain number of cases by polycythemia. This syndrome was thought to be different from 854 the two other forms of alcoholic heart disease already known, namely, the beriberi form2 and the form characterized essentially by the presence of myocardial fibrosis.3 At the end of 1966 a new acute form of myocardial disease with a high mortality was described in chronic alcoholics in Canada and in the U.S.A., whereby cobalt, having been used as an additive in beer, was implicated as a possible cause of the disease.810 A comparison of the two materials made a common origin between the cases in North America and our cases likely. The purpose of this paper is to present supplementary clinical cases and data on the natural history of the disease and further evidence of the importance of cobalt in the genesis of the syndrome. Finally, the importance of nutritional factors and of the remaining problems will be stressed.
hemoglobin value of the whole group. Included in the study also were eight cases that were discovered after the original paper was presented for publication. The average duration of the follow-up was 2.8 years, with a range between 0.5 and 5 years. All of these patients were male and drank an average of 17.6 glasses of beer a day. They all drank brands of beer that contained cobalt at the time that their disease was discovered. Two additional cases have been discovered after Belgian beer no longer contained cobalt. They seem to present the same syndrome however as the other cases, and they will be discussed separately.
To investigate the effects of cobalt on chronic alcoholics without heart complaints, 12 brewery workers were examined. These 12 workers all were heavy drinkers, and they had worked in two different breweries, both of which added cobalt to their beer. One of these breweries produced two brands of beer and a sample of one of the brands had the highest recorded concentration of cobalt in Belgian beer, namely 5 ppm. The other brand of the same brewery, which most of the workers drank, contained 1.2 ppm of cobalt. No cases of heart disease have come to our attention due to the brand of beer containing 5 ppm of cobalt. The concentration of cobalt in beer has been determined as the complex of cuprethol. The photospectrometric measurement has been done at 360 nanometers after correction for the presence of copper at 435 nanometers. In some cases cobalt was determined in the serum and urine by colorimetry using a modification of the method of Sandell sumption of between 1 and 5 glasses of beer a day, and two a consumption of between 6 and 10 glasses a day. One patient still drank 20 glasses of beer a day at the time of the followup study.
As noted in the original publication, anorexia was one of the predominant symptoms at the time of the initial illness, and the caloric intake from sources other than alcohol was of poor quality and quantity. At the time of the follow-up study all of the patients consumed a more diversified and appropriate quantity of food than at the time of their illness. However, we do not possess objective data on this matter.
Pericardial Effusion
This was found in 13 of the 16 13 published cases. In the total group, at the time of the initial illness, the circulation time was 20.6 ± 6.9 sec, and the left ventricular ejection time, determined from the indirect carotid artery tracing and corrected for heart rate from the tables of Willems and Kesteloot,12 was 81.6 ± 6.9% of normal. In the follow-up group the circulation time fell from a mean of 20.1 ± 6.8 sec to 12.3 ± 3.7 sec (P<0.0025) and the ejection time increased from a mean of 80± 6.4% of normal to 98 + 7.1% of normal. The correlation has been calculated between the hemoglobin value and the circulation time (r = 0.33, P < 0.1). The venous pressure, determined clinically, was normal, and none of the patients showed any signs of congestive heart failure at the time of the control study.
Liver Function Tests
No significant change was found in the follow-up group in the total mean protein value of 7 g% which remained unchanged, nor in the mean serum globulin value which changed from 1.06 g% to 0.91 g%. The mean serum glutamic oxalacetic transaminase (SGOT) value fell from 29.3 ± 12.4 IU to 19.7 Circulation, Volume XXXVII, May 1968 + 8.9 IU (P < 0.05) and the mean serum glutamic pyruvic transaminase (SGPT) value from 22 ± 10 IU to 18.9 + 2.6 IU. (This change was not statistically significant.) The serum iron, copper, and iron-binding capacity was determined in five patients at the time of their initial observation, and the results were normal in all. As noted in our original publication, important electrocardiographic changes were present in the patients. The most important changes were the presence of microvoltage and of important ST-T changes in lead I and in the left precordial leads. The ST-T changes consisted of negative T waves and ST-depressions. Moreover in three patients a QS pattern suggestive of myocardial infarction existed; in two patients in the right precordial leads and in one patient in standard leads II and III. In the 18 patients available for follow-up the mean total voltage of the three standard leads taken together containing both the R and the S waves, increased from 1.23 ± 0.47 to 1.67 + 0.67 mv. The R wave in lead II augmented from a mean of 0.38 ± 0.22 to 0.50 + 0.32 mv. In lead V6 the R wave increased from a mean value of 0.68 ± 0.29 to 0.81 ± 0.46 mv. In normals between 40 and 59 years of age the mean total voltage of the standard leads is 1.98 mv, and the mean voltage of the R wave in lead II is 0.75 + 0.33 mv and in lead V6 1.05 ± 0.35 mv.13 These findings together with their statistical significance are summarized in table 1. In eight of the patients the ST-T changes did not change on follow-up; in one patient they became worse; and in eight patients they became less pronounced. Although 11 patients were taking digitalis at the time of the follow-up, in only three of them were the changes thought to be due to digitalis alone. In two of the patients with QS changes Although in the beginning there were difficulties in differentiating the syndrome that was described7 from the classical forms of alcoholic heart disease, it rapidly became apparent that this was a new disease entity. The disease was called "alcoholic perimyocardiopathy" to emphasize the massive pericardial effusion and the hemodynamical changes that persisted for some time after the disappearance of the pericardial effusion. It was thought to be due to a direct influence of alcohol, although another toxic origin was not excluded.7
In the beginning of 1967 we became aware through correspondence with Professor Morin of the Laval University of Quebec that a similarity existed between our published cases7 and the cases he had observed in Quebec. The prevailing opinion in Canada was that the syndrome could be due to the addition of cobalt to beer.8 Cases similar to those of Quebec have been described in Omaha.9 Until that time we were unaware of the fact that cobalt was added to beer.
At the time of our first publication7 the whole processing of beer was followed in one of the biggest Belgian breweries in the presence of the chief biochemist. This brewery however had never added cobalt to its production, and it certainly was a bad choice because none of the patients drank beer produced by that brewery. This nant women. The anemia of pregnancy was prevented in this group, and no toxic manifestations were observed.'5 Cardiac toxicity has not been described in a study of cases of professional intoxication of humans working in cobalt mines or in industries engaged in the purification of cobalt.2' Cobalt has even been used for therapy in cases of hypertension in a dosage of 6 to 8 mg a day, and no toxic effects have been noted.22 Doses of cobalt of 2.5 mg/kg/day have been given to experimental animals for a period of 6 months. At autopsy, nothing special was found. In a dosage of 5 mg of cobalt/kg/day, no animal died after 5 months. At autopsy some myocardial edema without degeneration was noted. In a dosage of cobalt of 25 mg/kg/day the animals died after 1 month and massive pericardial effusion was noted. The myocardium was edematous; degeneration and swelling of the myocardial fibers were present with clarification and vacuolization of the cytoplasma.'8 Thus, very high concentrations of cobalt seem to be necessary to produce toxicity both in humans and in experimental animals. Cardiac toxicity is known however to exist during cobalt therapy.23 Cardiotoxicity developed in a case of aplastic anemia treated at our clinic and apparently cured by cobalt in a dosage of 10 mg a day during 4 months. Cardiac decompensation, cardiomegaly, and possibly pericardial effusion developed and disappeared after the treatment was stopped. The patient died 3 years later of lung cancer.
Only a small fraction of the population drinking beer containing cobalt developed manifest heart disease. This could be due to an abnormal sensitivity of certain subjects to cobalt or to a synergetic action by chance of different other factors in certain individuals. One factor however seems to differentiate the patients with heart disease from the other drinkers, and this is the profound anorexia that was present in almost all of them. This anorexia was also present in most of the patients who developed the disease in Quebec24 where only 16 In Quebec, of a total of 48 patients studied, 20 died and in Omaha 11 of a total of 28 patients died. Most patients died in profound shock and multiple arterial emboli were seen. Shock is a known complication of the intravenous administration of cobalt. It has been found in the dog that the intravenous administration of 3 mg of cobalt/kg lowers the blood pressure to between 50 and 70% of the initial value. This is not due to a direct action of cobalt on the heart, as its action in this concentration has been shown to be positively inotropic.37 It is explained by the vasodilating Circulation. Volume XXXVII, AMay 1968 effects of cobalt, due to a diminution in sympathetic tone.37 38 Shock is also a complication of the acute form of beri-beri, called shoshin. The massive pericardial effusion could also contribute to the development of shock.
Only one of our 24 patients died, 13P years after the original discovery of this disease. He became prostrated and died within 24 hours. He was known to have continued to drink beer containing cobalt in large quantities. One patient was in shock during his admission to the hospital. He survived following the administration of thiamine, norepinephrine, nalorphine, epinephrine, digitalis (Digitali), and fluid. This difference in mortality between the American and our series remains unexplained. Difference in diet between the two groups and a slightly higher alcoholic intake could be a factor in explaining the more acute toxicity in Canada. The possible role of a nutritional deficiency was also accepted by the American authors.8 The Hgb value of our group was 18.4 ± 2.0 g% and this is distinctly higher than the values observed in Omaha and Quebec,39 where they were 16.3 ± 2.1 g% and 16.4 + 1.6 g%, respectively (personal communication from Y. Morin). This difference could be due to the fact that cobalt has been present in Belgian beer for a much longer time than in the American beer.
The prognosis in our series was good. At the time of the follow-up all the patients took a more adequate diet. Their hemoglobin value, heart volume, LVET, circulation time, and venous pressure became normal. The electrocardiographic tracing, however, only rarely normalized, and in several patients important ST-T changes and the presence of microvoltage persisted. Liver function was within normal limits at the stage of the acute illness and remained so at the time of the follow-up study. In one patient a myocardial biopsy has been taken during the receding state of the disease, and the myocardium appeared normal by microscopic examination. In the American series cellular degeneration with vascular degeneration and edema with absence of inCirculation, Volume XXXVII, May 1968 flammatory changes or fibrosis was present in the myocardium of the patients who died.
The origin of the pericardial effusion remains unknown. There is no doubt that the important cardiomegalia was nearly exclusively due to the pericardial effusion. In all the cases in which the pericardial fluid disappeared within 24 hours after the making of some holes in the pericardium with a pericardial puncture needle, the heart volume was normal or near normal. Fluid did not again accumulate except in one patient, who continued drinking beer containing cobalt; it disappeared however after he finally stopped drinking. Pericardial effusion has also been described in chronic alcoholics drinking beer without cobalt. 40 As cobalt was not quantitatively measured however in the beer consumed, this should be accepted with some reserve.
This syndrome is a typical example of the challenge that modern food processing presents to public health. A continuous watch will be necessary to prevent the recurrence of such events in the future.
